AWM
RNAC icon

Activest Wealth Management’s Cartesian Therapeutics RNAC Stock Holding History

Activest Wealth Management’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$688 Hold
66
– – ﹤0.01% 1017
2026
Q1 		$406 Hold
66
– – ﹤0.01% 1088
2025
Q4 		$476 Hold
66
– – ﹤0.01% 1002
2025
Q3 		$675 Hold
66
– – ﹤0.01% 931
2025
Q2 		$686 Hold
66
– – ﹤0.01% 822
2025
Q1 		$870 Hold
66
– – ﹤0.01% 785
2024
Q4 		$1.18K Hold
66
– – ﹤0.01% 456
2024
Q3 		$1.06K Hold
66
– – ﹤0.01% 457
2024
Q2 		$1.78K Buy
+66
New +$1.57K ﹤0.01% 407

Other funds holding RNAC

FA
Fedenia Advisers Madison, Wisconsin $421M AUM 96.46% 1-Year Est. Return
TFCP
Twin Focus Capital Partners Boston, Massachusetts $983M AUM 37.07% 1-Year Est. Return
MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Activest Wealth Management's RNAC Position: Q2 2026 in Review

Activest Wealth Management held its Cartesian Therapeutics (RNAC) position steady in Q2 2026 at 66 shares worth $688. The position accounts for ﹤0.01% of the portfolio, ranked #1017.

Activest Wealth Management first reported a position in RNAC in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.78K in Q2 2024. 17 funds tracked by Wall St. Rank hold RNAC as of Q2 2026.

  • Activest Wealth Management held 66 shares of Cartesian Therapeutics worth $688 as of Q2 2026.
  • Activest Wealth Management left its Cartesian Therapeutics share count unchanged in Q2 2026.
  • Cartesian Therapeutics made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #1017 holding.
  • Activest Wealth Management first reported a position in Cartesian Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Activest Wealth Management's Cartesian Therapeutics position peaked at $1.78K in Q2 2024.
  • 17 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.